共 228 条
[1]
Garnero P(1996)Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis J Bone Miner Res 11 337-349
[2]
Somay-Rendu E(2003)Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women’s Health Initiative Randomized Trial JAMA 289 3243-3253
[3]
Chapuy MC(2003)Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 419-427
[4]
Delmas PD(2000)Effects of Raloxifene, a selective estrogen receptor modulator, on thymus, T cell reactivity, and inflammation in mice Cell Immunol 205 103-109
[5]
Chlebowski RT(2003)Gastrointestinal side effects of drugs Expert Opin Drug Safety 2 421-429
[6]
Hendrix SL(2002)Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis—a 2-year randomized placebo controlled trial J Clin Endocrinol Metab 87 2060-2066
[7]
Langer RD(2004)Isosorbide mononitrate increases bone formation and decreases bone resorption in postmenopausal women: a randomized trial J Bone Miner Res 19 1512-1517
[8]
Stefanick ML(2006)Anabolic therapy for osteoporosis: parathyroid hormone Curr Rheumatol Rep 8 63-69
[9]
Gass M(2005)Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use Endocr Rev 26 688-703
[10]
Lane D(2009)Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women Osteoporos Int 20 1603-1611